Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

BUY
$10.73 - $12.58 $13,981 - $16,391
1,303 Added 2.43%
54,926 $616,000
Q1 2024

Apr 16, 2024

BUY
$11.7 - $14.98 $7,604 - $9,737
650 Added 1.23%
53,623 $665,000
Q4 2023

Feb 05, 2024

BUY
$13.09 - $14.98 $10,458 - $11,969
799 Added 1.53%
52,973 $740,000
Q3 2023

Oct 13, 2023

BUY
$12.64 - $14.99 $659,479 - $782,088
52,174 New
52,174 $770,000

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.61B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Summer Haven Investment Management, LLC Portfolio

Follow Summer Haven Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summer Haven Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summer Haven Investment Management, LLC with notifications on news.